You are currently browsing the archives for 3 October 2017.
Displaying 1 entry.

Clinical study reviews and other clinical docs could be requested via the Boehringer Ingelheim site.

We deeply appreciate and are especially gratified by this implied trust from just one more world-course and forward-leaning drug development organization, who also happens to be a long-standing professional in R&D outsourcing. We anticipate working with Cenix, whose professional expertise, longstanding leadership and unrivaled track record in this field made them an ideal partner, commented Dr. Hiroaki Tanaka , Director of Personalized Medication, Debiopharm. The chance to benefit from such depth of knowledge, experience and extensively validated capabilities is recognized as the most strategically important resource for preclinical biomarkers discovery.